Purchase Order 36C24225P1200
Award Date
7/15/25
Potential Completion Date
9/30/25
Potential Value
$10K
Federal Agency
Veterans Integrated Service Network 2
Awardee
Accredo Health Group, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Bartlett, TN 38134, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, for the provision of DUOPA medication. The contract has a ceiling value of $10,122.32 and a period of performance ending on May 31, 2025. The contract was awarded on April 25, 2025 and is not set aside for any specific business type. Accredo Health Group, Inc. is a subsidiary of Express Scripts and specializes in...
This is a firm fixed-price purchase order contract awarded by the Veterans Integrated Service Network 2 (VISN 2), a civilian agency within the Department of Veterans Affairs (VA), to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract, valued at $10,122.32, is for the delivery of the specialty medication Duopa, which is used to treat Parkinson's disease. The contract has an ultimate completion date of August 1, 2025 and does not have a set-aside...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit specialty pharmacy company. The contract is for a 180-day supply of the medication Uptravi 600mcg, with a ceiling value of $78,557.34. The contract is not designated as a set-aside. Accredo Health Group, Inc. is a key distributor of complex and high-value medications to the VA's Veterans Integrated Service Networks (VISNs), with a focus on drugs...
This is a federal contract award to Accredo Health Group, Inc., a prime contractor, by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 21. The award is for the specialty medication UPTRAVI, with a potential value of $104,778.03 and a completion date of September 30, 2021. The contract is a firm fixed price purchase order with no set-aside designation. Accredo Health Group, a for-profit organization, provides specialty pharmacy...
The U.S. Department of Veterans Affairs (VA) awarded a $81,342.18 firm fixed-price purchase order contract to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, to provide the specialty pharmaceutical TYVASO. The contract, which does not have a set-aside designation, is to support the VA's Veterans Integrated Service Network 21 (VISN 21) and has an ultimate completion date of September 30, 2022. Accredo Health Group, Inc. is a key distributor of complex and...
This is a firm fixed-price purchase order award from the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Accredo Health Group, Inc., a for-profit pharmaceutical distribution company. The $38,493.36 contract is for the delivery of LUMRYZ 9GM/PKT (sodium oxybate), a specialty medication, to support the VHA's integrated healthcare networks. As a prime contractor, Accredo regularly fulfills purchase orders and multi-year contracts with the VA to supply specialty...
This is a firm fixed-price purchase order contract awarded by the Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company based in Memphis, Tennessee. The contract is for the delivery of the specialty medication treprostinil 53 mcg capsules, inhalation, to support the healthcare needs of veterans served by the VA's Veterans Integrated Service Network 2 (VISN 2). The contract has a total ceiling value of $17,490.24 and a period of...
This is a firm fixed-price purchase order contract awarded by the U.S. Department of Veterans Affairs (VA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract, valued at $94,899.21, is for the delivery of the drug Tyvaso, which is used to treat pulmonary arterial hypertension. The contract is not associated with a larger contract vehicle and does not have a set-aside designation. Accredo Health Group, Inc. is the prime contractor and there are no major...
This is a federal contract award to Accredo Health Group, Inc., a for-profit pharmacy benefit management company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 9 (VISN 9). The contract has a firm fixed-price of $7,509.56 for the purchase of the specialty pharmaceutical product Lumryz. The contract is a purchase order with a performance period from the award date of December 10, 2024 to the ultimate completion date of December 11, 2024. This contract award is...
This is a $113,770.56 firm fixed price purchase order contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) to Accredo Health Group, Inc., a for-profit pharmacy benefit management company. The contract is for the delivery of TYVASCO 0.6 MG, a specialty pharmaceutical product, to support veterans' healthcare through the VA's Veterans Integrated Service Network 21. The contract does not have a set-aside designation and will be performed at Accredo's...